Hot Two Shares to Ponder On: One Horizon Group, Inc. (NASDAQ:OHGI) ; Agile Therapeutics, Inc. (NASDAQ:AGRX)

One Horizon Group, Inc. (NASDAQ:OHGI)

One Horizon Group, Inc. (NASDAQ:OHGI) closed at $0.13 on the last trading session with an decrease of -4.62%, whereas, it previously closed at $0.13. The company has a market capitalization of $8.73 Million. The company traded shares of 1.71 Million on the trading day while its three month average volume stands at 4.04 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of One Horizon Group, Inc. (NASDAQ:OHGI) produced diluted EPS of -0.29. The EPS estimate for next year as estimated by analysts is at 0 while EPS for next quarter is estimated at 0. Earnings per Share growth for this year is reported at 17.3, while the analysts estimated the EPS growth for next year at 0% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -25.3%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of One Horizon Group, Inc. (NASDAQ:OHGI) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of One Horizon Group, Inc. (NASDAQ:OHGI) stands at 7.94 and Price to Book or P/B for the most recent quarter stands at 0.47. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of One Horizon Group, Inc. (NASDAQ:OHGI) are reported at 3 and 3 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for One Horizon Group, Inc. (NASDAQ:OHGI) stands at -64.4, -92.4 and 0 respectively

The trailing twelve month Revenue of One Horizon Group, Inc. (NASDAQ:OHGI) is reported at 1.1 Million with income of -11700000. The outstanding shares of One Horizon Group, Inc. (NASDAQ:OHGI) are 69.34 Million. The institutional Ownership of the shares of 7.3 stands at 0.80%, this figure is increased 0 in the last six months. The insider ownership for the shares of One Horizon Group, Inc. (NASDAQ:OHGI) is ticked at 17.4%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for One Horizon Group, Inc. (NASDAQ:OHGI) is the Mean Target Price estimated by the analysts which stands at 5.03. The 52 week high of One Horizon Group, Inc. (NASDAQ:OHGI) is placed at 3.03 and 52 week low is standing at 0.07.

Performance wise the shares of One Horizon Group, Inc. (NASDAQ:OHGI) fell down -4.98% for the week, it also fell -6.23% for the monthly performance, while for the quarter it went up -67.72%. The shares decrease -73.14% for the half year and flew up for the Year-To-Date performance. The shares of One Horizon Group, Inc. (NASDAQ:OHGI) shrinked -91.93% for the yearly performance.

Agile Therapeutics, Inc. (NASDAQ:AGRX)

Agile Therapeutics, Inc. (NASDAQ:AGRX) closed at $0.79 on the last trading session with an decrease of -0.59%, whereas, it previously closed at $0.79. The company has a market capitalization of $27.08 Million. The company traded shares of 227142 on the trading day while its three month average volume stands at 2.24 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Agile Therapeutics, Inc. (NASDAQ:AGRX) produced diluted EPS of -0.65. The EPS estimate for next year as estimated by analysts is at -0.5 while EPS for next quarter is estimated at -0.15. Earnings per Share growth for this year is reported at 10, while the analysts estimated the EPS growth for next year at -0.5% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 11.8%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Agile Therapeutics, Inc. (NASDAQ:AGRX) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Agile Therapeutics, Inc. (NASDAQ:AGRX) stands at 0 and Price to Book or P/B for the most recent quarter stands at 1.18. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Agile Therapeutics, Inc. (NASDAQ:AGRX) are reported at 2.1 and 2.1 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Agile Therapeutics, Inc. (NASDAQ:AGRX) stands at -54.9, -76.3 and 0 respectively

The trailing twelve month Revenue of Agile Therapeutics, Inc. (NASDAQ:AGRX) is reported at 0 with income of -22200000. The outstanding shares of Agile Therapeutics, Inc. (NASDAQ:AGRX) are 34.38 Million. The institutional Ownership of the shares of 44.1 stands at 0.80%, this figure is increased 0.04 in the last six months. The insider ownership for the shares of Agile Therapeutics, Inc. (NASDAQ:AGRX) is ticked at 1.15%, the figure is plummeted -43.1% in the last six months.

Some other important financial aspects to be discussed here for Agile Therapeutics, Inc. (NASDAQ:AGRX) is the Mean Target Price estimated by the analysts which stands at 3.33. The 52 week high of Agile Therapeutics, Inc. (NASDAQ:AGRX) is placed at 3.92 and 52 week low is standing at 0.23.

Performance wise the shares of Agile Therapeutics, Inc. (NASDAQ:AGRX) rose up 6.43% for the week, it also fell -2.09% for the monthly performance, while for the quarter it went down 10.93%. The shares increase 45.8% for the half year and flew up for the Year-To-Date performance. The shares of Agile Therapeutics, Inc. (NASDAQ:AGRX) shrinked -74.76% for the yearly performance.